WAVE3-NFκB interplay is essential for the survival and invasion of cancer cells

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Davuluri, Gangarao ^a   Augoff, Katarzyna ^a   Schiemann, William P ^b   Plow, Edward F ^a   Sossey Alaoui, Khalid ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSKELETON PROTEIN; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE B; PROTEIN WAVE3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; TNF PROTEIN, HUMAN; WASF3 PROTEIN, HUMAN; WISKOTT ALDRICH SYNDROME PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL; CELL DEATH; CELL INVASION; CELL NUCLEUS; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; GENE ACTIVATION; GENE LOSS; GENE TARGETING; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; MCF 7 CELL LINE; METABOLISM; METASTASIS; NEOPLASM; PATHOLOGY; PODOSOME; TUMOR INVASION;

EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 9; MCF-7 CELLS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; NF-KAPPA B; PODOSOMES; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; WISKOTT-ALDRICH SYNDROME PROTEIN FAMILY;

EID: 84908046785     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110627     Document Type: Article

References (45)

1. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674. S0092-8674(11)00127-9 [pii];10.1016/j.cell.2011.02.013 [doi].
2. Murphy DA, Courtneidge SA (2011) The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function. Nat Rev Mol Cell Biol 12: 413-426. nrm3141 [pii];10.1038/nrm3141 [doi].
3. Yamaguchi H (2012) Pathological roles of invadopodia in cancer invasion and metastasis. Eur J Cell Biol. S0171-9335(12)00081-7 [pii];10.1016/j.ejcb.2012.04.005 [doi].
4. Kurisu S, Takenawa T (2009) The WASP and WAVE family proteins. Genome Biol 10: 226. gb-2009-10-6-226 [pii];10.1186/gb-2009-10-6-226 [doi].
5. Caldieri G, Ayala I, Attanasio F, Buccione R (2009) Cell and molecular biology of invadopodia. Int Rev Cell Mol Biol 275: 1-34. S1937-6448(09)75001-4 [pii];10.1016/S1937-6448(09)75001-4 [doi].
6. Kurisu S, Takenawa T (2010) WASP and WAVE family proteins: friends or foes in cancer invasion? Cancer Sci 101: 2093-2104. CAS1654 [pii];10.1111/j.1349-7006.2010.01654.x [doi].
7. Sossey-Alaoui K, Li X, Ranalli TA, Cowell JK (2005) WAVE3-mediated cell migration and lamellipodia formation are regulated downstream of phosphatidylinositol 3-kinase. J Biol Chem 280: 21748-21755. M500503200 [pii];10.1074/jbc.M500503200 [doi].
8. Sossey-Alaoui K, Ranalli TA, Li X, Bakin AV, Cowell JK (2005) WAVE3 promotes cell motility and invasion through the regulation of MMP-1, MMP-3, and MMP-9 expression. Exp Cell Res 308: 135-145. S0014-4827(05)00187-4 [pii];10.1016/j.yexcr.2005.04.011 [doi].
9. Teng Y, Ren MQ, Cheney R, Sharma S, Cowell JK (2010) Inactivation of the WASF3 gene in prostate cancer cells leads to suppression of tumorigenicity and metastases. Br J Cancer 103: 1066-1075. 6605850 [pii];10.1038/sj.bjc.6605850 [doi].
10. Teng Y, Liu M, Cowell JK (2011) Functional interrelationship between the WASF3 and KISS1 metastasis-associated genes in breast cancer cells. Int J Cancer 129: 2825-2835. 10.1002/ijc.25964 [doi].
11. Fernando HS, Sanders AJ, Kynaston HG, Jiang WG (2010) WAVE3 is associated with invasiveness in prostate cancer cells. Urol Oncol 28: 320-327. S1078-1439(08)00381-5 [pii];10.1016/j.urolonc.2008.12.022 [doi].
12. Sossey-Alaoui K, Safina A, Li X, Vaughan MM, Hicks DG, et al. (2007) Down-regulation of WAVE3, a metastasis promoter gene, inhibits invasion and metastasis of breast cancer cells. Am J Pathol 170: 2112-2121. S0002-9440(10)61418-6 [pii];10.2353/ajpath.2007.060975 [doi].
13. Zhang Y, Guan XY, Dong B, Zhao M, Wu JH, et al. (2012) Expression of MMP-9 and WAVE3 in colorectal cancer and its relationship to clinicopathological features. J Cancer Res Clin Oncol. 10.1007/s00432-012-1274-3 [doi].
14. Kulkarni S, Augoff K, Rivera L, McCue B, Khoury T, et al. (2012) Increased Expression Levels of WAVE3 Are Associated with the Progression and Metastasis of Triple Negative Breast Cancer. PLOS ONE 7: e42895. 10.1371/journal.pone.0042895 [doi];PONE-D-12-13453 [pii].
15. Sossey-Alaoui K (2013) Surfing the big WAVE: Insights into the role of WAVE3 as a driving force in cancer progression and metastasis. Semin Cell Dev Biol 24: 287-297. S1084-9521(12)00186-3 [pii];10.1016/j.semcdb.2012.10.006 [doi].
16. Taylor MA, Davuluri G, Parvani JG, Schiemann BJ, Wendt MK, et al. (2013) Upregulated WAVE3 expression is essential for TGF-beta-mediated EMT and metastasis of triple-negative breast cancer cells. Breast Cancer Res Treat 142: 341-353. 10.1007/s10549-013-2753-1 [doi].
17. Chaturvedi MM, Sung B, Yadav VR, Kannappan R, Aggarwal BB (2011) NF-kappaB addiction and its role in cancer: 'one size does not fit all'. Oncogene 30: 1615-1630. onc2010566 [pii];10.1038/onc.2010.566 [doi].
18. Wu Y, Zhou BP (2010) TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion. Br J Cancer 102: 639-644. 6605530 [pii];10.1038/sj.bjc.6605530 [doi].
19. Ghosh S, Karin M (2002) Missing pieces in the NF-kappaB puzzle. Cell 109 Suppl: S81-S96. S0092867402007031 [pii].
20. O'Dea E, Hoffmann A (2009) NF-kappaB signaling. Wiley Interdiscip Rev Syst Biol Med 1: 107-115. 10.1002/wsbm.30 [doi].
21. Balkwill F (2009) Tumour necrosis factor and cancer. Nat Rev Cancer 9: 361-371. nrc2628 [pii];10.1038/nrc2628 [doi].
22. O'Dea E, Hoffmann A (2010) The regulatory logic of the NF-kappaB signaling system. Cold Spring Harb Perspect Biol 2: a000216. 10.1101/cshperspect.a000216 [doi].
23. Mattioli I, Sebald A, Bucher C, Charles RP, Nakano H, et al. (2004) Transient and selective NF-kappa B p65 serine 536 phosphorylation induced by T cell costimulation is mediated by I kappa B kinase beta and controls the kinetics of p65 nuclear import. J Immunol 172: 6336-6344.
24. Oner C, Schatz F, Kizilay G, Murk W, Buchwalder LF, et al. (2008) Progestin-inflammatory cytokine interactions affect matrix metalloproteinase-1 and -3 expression in term decidual cells: implications for treatment of chorioamnionitis-induced preterm delivery. J Clin Endocrinol Metab 93: 252-259. jc.2007-1538 [pii];10.1210/jc.2007-1538 [doi].
25. Sato H, Kita M, Seiki M (1993) v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines. J Biol Chem 268: 23460-23468.
26. Fortunato SJ, Menon R, Lombardi SJ (2002) Role of tumor necrosis factor-alpha in the premature rupture of membranes and preterm labor pathways. Am J Obstet Gynecol 187: 1159-1162. S0002937802003848 [pii].
27. Bialkowska K, Ma YQ, Bledzka K, Sossey-Alaoui K, Izem L, et al. (2010) The integrin co-activator Kindlin-3 is expressed and functional in a nonhematopoietic cell, the endothelial cell. J Biol Chem 285: 18640-18649. M109.085746 ;10.1074/jbc.M109.085746 [doi].
28. Sossey-Alaoui K, Pluskota E, Davuluri G, Bialkowska K, Das M, et al. (2014) Kindlin-3 enhances breast cancer progression and metastasis by activating Twist-mediated angiogenesis. FASEB J 28: 2260-2271. fj.13-244004 [pii];10.1096/fj.13-244004 [doi].
29. Stovold CF, Millard TH, Machesky LM (2005) Inclusion of Scar/WAVE3 in a similar complex to Scar/WAVE1 and 2. BMC Cell Biol 6: 11. 1471-2121-6-11 [pii];10.1186/1471-2121-6-11 [doi].
30. Sossey-Alaoui K, Downs-Kelly E, Das M, Izem L, Tubbs R, et al. (2011) WAVE3, an actin remodeling protein, is regulated by the metastasis suppressor microRNA, miR-31, during the invasion-metastasis cascade. Int J Cancer 129: 1331-1343. 10.1002/ijc.25793 [doi].
31. Yamaguchi H, Yoshida S, Muroi E, Yoshida N, Kawamura M, et al. (2011) Phosphoinositide 3-kinase signaling pathway mediated by p110alpha regulates invadopodia formation. J Cell Biol 193: 1275-1288. jcb.201009126 [pii];10.1083/jcb.201009126 [doi].
32. Agarwal E, Chaudhuri A, Leiphrakpam PD, Haferbier KL, Brattain MG, et al. (2014) Akt inhibitor MK-2206 promotes anti-tumor activity and cell death by modulation of AIF and Ezrin in colorectal cancer. BMC Cancer 14: 145. 1471-2407-14-145 [pii];10.1186/1471-2407-14-145 [doi].
33. Cheng Y, Zhang Y, Zhang L, Ren X, Huber-Keener KJ, et al. (2012) MK-2206, a novel allosteric inhibitor of Akt, synergizes with gefitinib against malignant glioma via modulating both autophagy and apoptosis. Mol Cancer Ther 11: 154-164. 1535-7163.MCT-11-0606 [pii];10.1158/1535-7163.MCT-11-0606 [doi].
34. Lai YC, Liu Y, Jacobs R, Rider MH (2012) A novel PKB/Akt inhibitor, MK-2206, effectively inhibits insulin-stimulated glucose metabolism and protein synthesis in isolated rat skeletal muscle. Biochem J 447: 137-147. BJ20120772 [pii];10.1042/BJ20120772 [doi].
35. Liu R, Liu D, Trink E, Bojdani E, Ning G, et al. (2011) The Akt-specific inhibitor MK2206 selectively inhibits thyroid cancer cells harboring mutations that can activate the PI3K/Akt pathway. J Clin Endocrinol Metab 96: E577-E585. jc.2010-2644 [pii];10.1210/jc.2010-2644 [doi].
36. Kant S, Swat W, Zhang S, Zhang ZY, Neel BG, et al. (2011) TNF-stimulated MAP kinase activation mediated by a Rho family GTPase signaling pathway. Genes Dev 25: 2069-2078. 25/19/2069 [pii];10.1101/gad.17224711 [doi].
37. Cho SG, Li D, Stafford LJ, Luo J, Rodriguez-Villanueva M, et al. (2009) KiSS1 suppresses TNFalpha-induced breast cancer cell invasion via an inhibition of RhoA-mediated NF-kappaB activation. J Cell Biochem 107: 1139-1149. 10.1002/jcb.22216 [doi].
38. Deryugina EI, Quigley JP (2006) Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25: 9-34. 10.1007/s10555-006-7886-9 [doi].
39. Naugler WE, Karin M (2008) NF-kappaB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev 18: 19-26. S0959-437X(08)00025-7 [pii];10.1016/j.gde.2008.01.020 [doi].
40. Scott JD (2003) A-kinase-anchoring proteins and cytoskeletal signalling events. Biochem Soc Trans 31: 87-89. 10.1042/[doi].
41. Sossey-Alaoui K, Li X, Cowell JK (2007) c-Abl-mediated phosphorylation of WAVE3 is required for lamellipodia formation and cell migration. J Biol Chem 282: 26257-26265. M701484200 [pii];10.1074/jbc.M701484200 [doi].
42. Sossey-Alaoui K, Bialkowska K, Plow EF (2009) The miR200 family of microRNAs regulates WAVE3-dependent cancer cell invasion. J Biol Chem 284: 33019-33029. M109.034553 [pii];10.1074/jbc.M109.034553 [doi].
43. Deorukhkar A, Krishnan S (2010) Targeting inflammatory pathways for tumor radiosensitization. Biochem Pharmacol 80: 1904-1914. S0006-2952(10)00473-9 [pii];10.1016/j.bcp.2010.06.039 [doi].
44. Mizutani K, Koike D, Suetsugu S, Takenawa T (2005) WAVE3 functions as a negative regulator of LDOC1. J Biochem 138: 639-646. 138/5/639 [pii];10.1093/jb/mvi160 [doi].
45. Nagasaki K, Schem C, von KC, Biallek M, Rosel F, et al. (2003) Leucine-zipper protein, LDOC1, inhibits NF-kappaB activation and sensitizes pancreatic cancer cells to apoptosis. Int J Cancer 105: 454-458. 10.1002/ijc.11122 [doi].